Adrock !? .....
can't understand why some people are already frustrated with Innovus on just the third day of trading for the new year.
Nothing has changed from last week, or two weeks ago or for that matter, two months ago. The company is still waiting for the FDA approval for its ANDA which we all know can take up to 36 months. Granted we are impatient but no bad news has been released. There is no dilution of shares. Innovus has not increased the shares outstanding since the approval and intends to do so only with specific purposes which will accelerate growth. The vote merely gave the CEO the flexibility to do so if an appropriate opportunity arises. Also (and I posted this before) the CEO purchased his $2.5 million worth of shares (6.25 million shares) at a 0.40 cent cost basis and I am positive is very cognizant of appropriate uses for any additional shares. I know that people on this board have expressed concerns about dilution but let's not create panic. Granted dilution without increasing shareholder value is always a negative. But if dilution increases future earnings and revenue at a rate faster than increased share count, then that is positive or accretive. Almost all mid-sized and large companies have utilized accretive dilution as an appropriate way to deliver increased shareholder value and have done so at many points in their history. So why all the fuss? Nothing has changed.
I have realistic expectations of Innovus as the new year starts. I am not going to panic when this stock moves down or up by 2 or 3 or 5 cents. The malicious market-makers are trying to short INNV but are not having much luck.
None of the nine (9) institutional investors is trying to sell and they have over 12 million shares.
These nine investors gave INNV $3 million in exchange for 12 million shares (priced at 0.25) and almost all that debt has now been converted before the maturity date so there is no issue there. While I am not able to speculate on what these investors will do in the future, I can hypothesize that they want INNV to go as high as it has the potential to go.
By the way, I am not making this stuff up. Please feel free to review a previous S1 (filed with the SEC 8/9/16), Pg-3.
Team my plan is to listen to the Q4 2016 earnings call (in mid-Feb), patiently wait for the FDA approval, get positive guidance for 2017 and gradually see the SP go up later this year. I own a lot of shares (more than I should own) but I truly believe in this company and its mid to long-term success possibilities. This company will not evaporate as some may have suggested. I am not going to get frustrated every day when this stock bounces-around because the fundamentals for INNV are in good shape despite the MM trying their best to manipulate/derail it. Hang-in there longs; our day is coming.
See Less
AI
